This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): D-4F
Description: D-4F is an oral apolipoprotein A-I (apoA-I) mimetic peptide. It contains 18 amino acids, versus 243 for apoA-I. apoA-I is the major protein of HDL particles, the good cholesterol that removes excess cholesterol and other lipids from artery walls and other tissues.
Deal Structure: In 2004, Novartis licensed APP018 from Bruin Pharmaceuticals.
Partners: Bruin Pharmaceuticals
Pink Sheet Weekly Trademark Review Dec. 6, 2016
Pink Sheet Weekly Trademark Review June 9, 2015
Pink Sheet Weekly Trademark Review Dec. 24, 2013
Additional information available to subscribers only: